We describe the sequence and expression pattern of Sp5, a novel member of the vertebrate Sp1 transcription factor gene family which consists of at least ®ve members. This gene family is characterized by a highly conserved domain which is formed by three Zn ®ngers, which bind to the GC box or the GT/CACC box in the promoter of many genes. These boxes are important cis-acting elements required for the expression of the respective genes. In vitro experiments indicate that the Sp1 transcription factors act by in¯uencing the methylation state of the DNA, or by direct interactions with other promoter speci®c transcription factors. Despite intensive research, the results from in vivo experiments, including targeted gene inactivation, have been dif®cult to explain. This may be due to possible redundancies and interferences with other transcription factors of this gene family. Here, we report the isolation of the mouse Sp5 gene, a novel Sp1 homolog. Its sequence indicates that Sp5 is a possible link between Sp1 and the closely related BTEB/KLF gene family. We provide detailed information of its highly dynamic expression pattern during mouse embryogenesis in the developing brain, the spinal cord, the trigeminal ganglia, the somites and additional sites outside the nervous system starting from embryonic day 7.25 (E7.25) up to E10.5. q
Results
A PCR based approach was used to clone Sp1 gene family homologs. Degenerate PCR primers were designed on the basis of the conserved Zn ®nger domain. The pair cgccaggtgatcrctickcatraaic (5 H ) and cacatctgccayatycciggitgygarmg (3 H ) ampli®ed on genomic mouse DNA a characteristic Sp1-type Zn ®nger box of 231 nucleotides (annealing at 478C; 40 cycles). This fragment was used to screen an E8.5 mouse cDNA library (kindly provided by Brigid Hogan). We obtained a 1255 bp fragment of a cDNA sequence including the poly(A). From the NCBI entry AF279479, 636 bp were added 5 H to our sequence (length of the entry, 1825). Our sequence is identical to AF279479, except for an additional 53 bp at the 3 H end (TTCCAGGGTCTCCTCGGGAAGACCCCCACAGAA-AAAAAAAAAAAAAAAAAAAA).
As shown in Fig. 1A ,B, the Sp5 gene belongs to the Sp1 transcription factor family, which is characterized by typical Zn ®nger and buttonhead regions (El-Baradi and Pieler, 1991; Wimmer et al., 1993 Wimmer et al., , 1996 . Outside of these domains, the Sp5 protein shows little similarity to other Sp1 homologs, which contain S/T-rich and Q-rich stretches. Instead, in the latter region, Sp5 is similar to the evolutionary homologous but distinct BTEB/KLF group, characterized by a high content of proline residues (about 20%; Fig.  1C ; Philipsen and Suske, 1999) . Members of the BTEB/ KLF group have a distinct Zn ®nger domain and lack the buttonhead domain. Therefore, the Sp5 gene has probably been generated during evolution by a domain swapping between a Sp1 and a BTEB/KLF homolog.
The in situ hybridization (ISH) revealed a highly dynamic and speci®c expression pattern, which appears to be subdivided into two phases (Figs. 2 and 3): an early activity which is connected to the process of gastrulation, and a second wave of expression during organogenesis.
Early expression of Sp5
At E7.25 (Figs. 2A, B and 3A) , Sp5 is expressed in the entire region of the primitive streak. In the cells of the embryo proper (primitive ectoderm and ingressing mesoderm), Sp5 mRNA is transcribed, but not in the underlying visceral endoderm (arrows in Fig. 3A) . The lateral constriction of the expression is unclear, since the lateral most mesoderm and ectoderm are also negative (data not shown). Later on, the signal remains con®ned to the primitive streak at the end of the embryo (Fig. 2E±J) . At E8.25, the gene is expressed in the posterior end of the neural plate and the underlying mesoderm (Fig. 3C) . The visceral endoderm is still negative (data not shown). With the formation of the gut, the de®nitive endoderm also becomes positive (arrow in Fig. 3C ), as well as the notochord (double arrow in Fig. 3C ). At E10.25 and later stages, the primary gastrulation has ®nished and the secondary gastrulation starts in the posterior tip of the embryo, the tail bud. Its mesenchymal tissue strongly expresses Sp5 (Figs. 2J and 3D,E), while the surrounding ectoderm is negative (arrow in Fig. 3E ). Interestingly, after the switch in the gastrulation and notochord formation, the notochord still expresses Sp5 (arrow in Fig. 3D ), but exclusively in a single cell (double arrow in Fig. 3F ) surrounded by Sp5-negative notochordal cells (arrows in Fig. 3F ).
Sp5 expression in the developing brain
At E8.0, the expression during organogenesis starts in the CNS as a faint ISH signal in the mesencephalon and diencephalon (arrows in Figs. 2E,F and 4A). At E8.5, the mRNA level becomes very strong in the dorso-lateral regions of the same domains (Fig. 4B,I ). In the diencephalon, the Sp5-mRNA is restricted to the region of the prospective pretectum and epithalamus (Fig. 4B ). The telencephalon shows no staining up to E10.5. (m, mouse; h, human) . Note that the proteins Sp1±Sp5 all contain the conserved btd box about 18 amino acids in front of the Zn ®nger domains, while the more distantly related genes belonging to the BTEB/KLF family lack this domain. In contrast, they contain conserved sequences (black boxes) that are not found in the Sp1-like proteins. (C) Schematic drawing representing the deduced proteins of the Sp1 and the BTEB/KLF family. The scheme is drawn to scale. The region of the btd and Zn ®nger domains is symbolized by green boxes and represents the deduced sequences in (B). The purple boxes represent glutamine-rich domains, the red boxes serine/threonine-rich stretches, and the blue boxes represent proline-rich domains. Note that Sp5 is homologous to Sp1 regarding the btd and Zn ®nger domain, while the rest of the protein is homologous to the BTEB/KLF family like BTEB2, BTEB3, TIEG1, TIEG2, EKLF or LKLF.
Until stage E9.5, both the dorsal and lateral regions of the mesencephalon are Sp5-positive (arrow in Fig. 2H ), but the lateral expression gradually disappears between E10.0 and E10.5 (arrows in Figs. 2I,J and 4C). However, the midbrain± hindbrain boundary (MHB) shows a strong hybridization signal throughout its entire dorso-ventral axis, except for the roofplate (arrow in Fig. 4D ) and the¯oorplate (arrow in Fig. 4F ). In addition, in the midbrain, Sp5 starts to be expressed from E10.0 onwards in the tegmentum (tm in Fig.  4F±H ), while the mesencephalic¯oorplate is Sp5-negative (arrow in Fig. 4F) .
In contrast to the mesencephalon, the pretectum also expresses Sp5 in lateral and ventral regions, at least until E10.5. Here, the transcripts are detectable as a stripe at the base of the pretectum and hypothalamus, within the anlage of the mammilary bodies (mb in Fig. 4F±H,J) . Noteworthy, in the entire¯oorplate of the brain, only the hypothalamus is Sp5-positive (Fig. 4J ).
Sp5 expression in the developing spinal cord
In the spinal cord, Sp5 expression is ®rst detectable around E8.0. The hybridization signal has a peak within the upper thoraxic region and fades towards the rhomben- Fig. 2 . Sp5 shows two phases of expression during gastrulation and organogenesis. Whole-mount in situ hybridizations on mouse embryos from E7.25 to E10.5. The hybridizations were done with a PmlI fragment containing the 3 H part of the cDNA up to nt 676 as previously described. In (A±D) the anterior is to the left, and the posterior is to the right. The arrows in (E,F) point to the starting CNS expression, the arrows in (H±J) point to the fading expression in the lateral mesencephalon. . ant, anterior; d, dorsal; e, anlage of the epithalamus; ec, ectoderm; en, endoderm; m, mesencephalon; mb, anlage of the mammilary body; nt, neural tube; ov, otic vesicle; p, pretectum; post, posterior; sc, spinal cord; t, telencephalon; tec, prospective tectum of the mesencephalon; tm, tegmentum of the mesencephalon; 1, 2, 3, 4, branchial arches; 4v, fourth ventricle. ISH was performed according to Wilkinson (1992) . The anatomical analysis was done according to Puelles and Rubenstein (1993) . cephalon and the tail bud. Along the dorso-ventral axis, the expression is con®ned to the dorsal most part of the alar plate (Fig. 4K,L) .
Additional sites of Sp5 expression
At around E10.0, the trigeminal ganglia are strongly positive (arrow in Fig. 4P,Q) . Furthermore, the neurogenic otic placodes/vesicles express Sp5. The initially (E9.00) faint ISH signal becomes very strong in the otic vesicles at E10.0, and is con®ned to its medio-dorsal part (Fig. 4M±O) .
In addition, the branchial (pharyngeal) arch system, the somites and the limbs show a dynamic Sp5 expression. While the ®rst three branchial pouches (endoderm) and clefts (ectoderm) express the gene continuously between E8.5 and 10.5 (Fig. 4R±T) , the fourth pouch and cleft are Sp5-negative (Fig. 4T) . In the somites, the mRNA is only brie¯y detectable. About 2 h after the generation of an individual somite, Sp5 is expressed in its dorsal tip which will develop into the epaxial dermomyotome lip. Sp5-mRNA levels reach a peak after about 15 h (arrows in Fig. 4U±X ) and gradually fade away during the maturation of the individual somite.
In the limb buds, the Sp5 gene is ®rst expressed dorsally in scattered cells within the mesenchyme at E10.50 (arrow in Fig. 4Y ). Later on, Sp5-positive cells are also found in the ventral part (data not shown).
